| UniProt ID | CDCA7_HUMAN | |
|---|---|---|
| UniProt AC | Q9BWT1 | |
| Protein Name | Cell division cycle-associated protein 7 | |
| Gene Name | CDCA7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 371 | |
| Subcellular Localization | Nucleus. Cytoplasm. Predominantly nuclear with some expression also seen in the cytoplasm. Predominantly cytoplasmic when phosphorylated at Thr-163. | |
| Protein Description | Participates in MYC-mediated cell transformation and apoptosis; induces anchorage-independent growth and clonogenicity in lymphoblastoid cells. Insufficient to induce tumorigenicity when overexpressed but contributes to MYC-mediated tumorigenesis. May play a role as transcriptional regulator.. | |
| Protein Sequence | MDARRVPQKDLRVKKNLKKFRYVKLISMETSSSSDDSCDSFASDNFANTRLQSVREGCRTRSQCRHSGPLRVAMKFPARSTRGATNKKAESRQPSENSVTDSNSDSEDESGMNFLEKRALNIKQNKAMLAKLMSELESFPGSFRGRHPLPGSDSQSRRPRRRTFPGVASRRNPERRARPLTRSRSRILGSLDALPMEEEEEEDKYMLVRKRKTVDGYMNEDDLPRSRRSRSSVTLPHIIRPVEEITEEELENVCSNSREKIYNRSLGSTCHQCRQKTIDTKTNCRNPDCWGVRGQFCGPCLRNRYGEEVRDALLDPNWHCPPCRGICNCSFCRQRDGRCATGVLVYLAKYHGFGNVHAYLKSLKQEFEMQA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Ubiquitination | DARRVPQKDLRVKKN CCCCCCHHHHHHHHH | 53.30 | - | |
| 9 | Acetylation | DARRVPQKDLRVKKN CCCCCCHHHHHHHHH | 53.30 | 23749302 | |
| 9 (in isoform 2) | Ubiquitination | - | 53.30 | - | |
| 9 | Ubiquitination | DARRVPQKDLRVKKN CCCCCCHHHHHHHHH | 53.30 | - | |
| 9 | Acetylation | DARRVPQKDLRVKKN CCCCCCHHHHHHHHH | 53.30 | - | |
| 27 (in isoform 2) | Phosphorylation | - | 22.47 | 24144214 | |
| 30 (in isoform 2) | Phosphorylation | - | 25.85 | 24144214 | |
| 31 | Phosphorylation | KLISMETSSSSDDSC EEEEEECCCCCCCCC | 18.21 | 28634120 | |
| 31 (in isoform 2) | Phosphorylation | - | 18.21 | 24144214 | |
| 32 (in isoform 2) | Phosphorylation | - | 41.08 | 24144214 | |
| 33 | Ubiquitination | ISMETSSSSDDSCDS EEEECCCCCCCCCHH | 37.24 | - | |
| 33 (in isoform 2) | Phosphorylation | - | 37.24 | 24144214 | |
| 34 (in isoform 2) | Phosphorylation | - | 47.59 | 24144214 | |
| 37 (in isoform 2) | Phosphorylation | - | 25.47 | 24144214 | |
| 43 (in isoform 2) | Phosphorylation | - | 30.95 | 24144214 | |
| 67 | Phosphorylation | TRSQCRHSGPLRVAM CHHHCCCCCCEEEEE | 23.82 | 24719451 | |
| 75 | Ubiquitination | GPLRVAMKFPARSTR CCEEEEEECCCCCCC | 38.16 | - | |
| 75 | Sumoylation | GPLRVAMKFPARSTR CCEEEEEECCCCCCC | 38.16 | - | |
| 75 | Sumoylation | GPLRVAMKFPARSTR CCEEEEEECCCCCCC | 38.16 | - | |
| 75 | Acetylation | GPLRVAMKFPARSTR CCEEEEEECCCCCCC | 38.16 | 25953088 | |
| 80 | Phosphorylation | AMKFPARSTRGATNK EEECCCCCCCCCCCC | 25.27 | - | |
| 81 | Phosphorylation | MKFPARSTRGATNKK EECCCCCCCCCCCCC | 27.80 | - | |
| 81 | Ubiquitination | MKFPARSTRGATNKK EECCCCCCCCCCCCC | 27.80 | - | |
| 84 | Ubiquitination | PARSTRGATNKKAES CCCCCCCCCCCCCCC | 12.52 | - | |
| 89 | Ubiquitination | RGATNKKAESRQPSE CCCCCCCCCCCCCCC | 22.93 | - | |
| 91 | Phosphorylation | ATNKKAESRQPSENS CCCCCCCCCCCCCCC | 40.87 | 21406692 | |
| 95 | Phosphorylation | KAESRQPSENSVTDS CCCCCCCCCCCCCCC | 40.86 | 28450419 | |
| 98 | Phosphorylation | SRQPSENSVTDSNSD CCCCCCCCCCCCCCC | 23.49 | 28450419 | |
| 100 | Phosphorylation | QPSENSVTDSNSDSE CCCCCCCCCCCCCCC | 33.27 | 28450419 | |
| 102 | Phosphorylation | SENSVTDSNSDSEDE CCCCCCCCCCCCCCH | 28.94 | 28450419 | |
| 104 | Phosphorylation | NSVTDSNSDSEDESG CCCCCCCCCCCCHHH | 46.60 | 28450419 | |
| 106 | Phosphorylation | VTDSNSDSEDESGMN CCCCCCCCCCHHHHH | 46.93 | 28450419 | |
| 110 | Phosphorylation | NSDSEDESGMNFLEK CCCCCCHHHHHHHHH | 56.52 | 28450419 | |
| 117 | Acetylation | SGMNFLEKRALNIKQ HHHHHHHHHHHCHHH | 45.15 | 26051181 | |
| 123 | Ubiquitination | EKRALNIKQNKAMLA HHHHHCHHHHHHHHH | 46.90 | 22505724 | |
| 123 | Acetylation | EKRALNIKQNKAMLA HHHHHCHHHHHHHHH | 46.90 | 25953088 | |
| 126 | Ubiquitination | ALNIKQNKAMLAKLM HHCHHHHHHHHHHHH | 32.45 | 29967540 | |
| 131 | Ubiquitination | QNKAMLAKLMSELES HHHHHHHHHHHHHHC | 40.54 | - | |
| 131 | Sumoylation | QNKAMLAKLMSELES HHHHHHHHHHHHHHC | 40.54 | - | |
| 131 | Sumoylation | QNKAMLAKLMSELES HHHHHHHHHHHHHHC | 40.54 | - | |
| 138 | Phosphorylation | KLMSELESFPGSFRG HHHHHHHCCCCCCCC | 49.74 | 26074081 | |
| 142 | Phosphorylation | ELESFPGSFRGRHPL HHHCCCCCCCCCCCC | 16.41 | 26074081 | |
| 146 (in isoform 2) | Phosphorylation | - | 24.80 | 24719451 | |
| 152 | Phosphorylation | GRHPLPGSDSQSRRP CCCCCCCCCCCCCCC | 31.95 | 28555341 | |
| 154 | Phosphorylation | HPLPGSDSQSRRPRR CCCCCCCCCCCCCCC | 31.58 | 28555341 | |
| 154 (in isoform 2) | Ubiquitination | - | 31.58 | - | |
| 162 | Ubiquitination | QSRRPRRRTFPGVAS CCCCCCCCCCCCHHH | 41.83 | - | |
| 163 | Phosphorylation | SRRPRRRTFPGVASR CCCCCCCCCCCHHHC | 32.16 | 30576142 | |
| 168 | Ubiquitination | RRTFPGVASRRNPER CCCCCCHHHCCCHHH | 11.84 | - | |
| 170 | Ubiquitination | TFPGVASRRNPERRA CCCCHHHCCCHHHHC | 32.43 | - | |
| 174 (in isoform 2) | Phosphorylation | - | 59.35 | 21406692 | |
| 175 | Ubiquitination | ASRRNPERRARPLTR HHCCCHHHHCCCCCH | 38.52 | 22505724 | |
| 177 (in isoform 2) | Phosphorylation | - | 24.54 | 21406692 | |
| 179 (in isoform 2) | Phosphorylation | - | 36.78 | 21406692 | |
| 181 (in isoform 2) | Phosphorylation | - | 29.31 | 21406692 | |
| 183 (in isoform 2) | Phosphorylation | - | 29.40 | 21406692 | |
| 185 (in isoform 2) | Phosphorylation | - | 25.56 | 21406692 | |
| 190 | Phosphorylation | SRSRILGSLDALPME HHHHHHHCCCCCCCC | 21.45 | 28674151 | |
| 202 (in isoform 2) | Ubiquitination | - | 64.18 | - | |
| 202 | Ubiquitination | PMEEEEEEDKYMLVR CCCCHHHHHCEEEEE | 64.18 | 22505724 | |
| 204 | Sumoylation | EEEEEEDKYMLVRKR CCHHHHHCEEEEECC | 35.52 | 28112733 | |
| 204 | Ubiquitination | EEEEEEDKYMLVRKR CCHHHHHCEEEEECC | 35.52 | - | |
| 205 | Ubiquitination | EEEEEDKYMLVRKRK CHHHHHCEEEEECCC | 14.17 | 29967540 | |
| 205 (in isoform 2) | Ubiquitination | - | 14.17 | - | |
| 205 | Phosphorylation | EEEEEDKYMLVRKRK CHHHHHCEEEEECCC | 14.17 | 28796482 | |
| 210 | Ubiquitination | DKYMLVRKRKTVDGY HCEEEEECCCCCCCC | 51.25 | 22505724 | |
| 210 (in isoform 2) | Ubiquitination | - | 51.25 | - | |
| 212 | Ubiquitination | YMLVRKRKTVDGYMN EEEEECCCCCCCCCC | 56.80 | 22505724 | |
| 213 | Phosphorylation | MLVRKRKTVDGYMNE EEEECCCCCCCCCCH | 28.06 | 28555341 | |
| 229 | Phosphorylation | DLPRSRRSRSSVTLP HCCCCHHCCCCCCHH | 35.09 | 25627689 | |
| 231 | Phosphorylation | PRSRRSRSSVTLPHI CCCHHCCCCCCHHHE | 30.33 | 25627689 | |
| 242 | Phosphorylation | LPHIIRPVEEITEEE HHHEECCHHHCCHHH | 8.07 | 32645325 | |
| 262 | Ubiquitination | SNSREKIYNRSLGST CCCHHHHHHCHHCHH | 18.65 | 22505724 | |
| 264 | Ubiquitination | SREKIYNRSLGSTCH CHHHHHHCHHCHHHH | 19.11 | 22505724 | |
| 269 (in isoform 2) | Phosphorylation | - | 16.53 | 24719451 | |
| 276 | Ubiquitination | TCHQCRQKTIDTKTN HHHHHHHHCCCCCCC | 28.26 | 29967540 | |
| 280 (in isoform 3) | Phosphorylation | - | 35.60 | 30631047 | |
| 283 (in isoform 2) | Ubiquitination | - | 25.06 | - | |
| 284 (in isoform 2) | Phosphorylation | - | 5.57 | 27642862 | |
| 289 | Ubiquitination | TNCRNPDCWGVRGQF CCCCCCCCCCCCCCC | 3.43 | 22505724 | |
| 289 (in isoform 2) | Ubiquitination | - | 3.43 | - | |
| 291 | Ubiquitination | CRNPDCWGVRGQFCG CCCCCCCCCCCCCCH | 12.94 | 22505724 | |
| 291 (in isoform 2) | Ubiquitination | - | 12.94 | - | |
| 307 | Ubiquitination | CLRNRYGEEVRDALL HHHHCCCHHHHHHHH | 44.37 | - | |
| 319 | Ubiquitination | ALLDPNWHCPPCRGI HHHCCCCCCCCCCCE | 22.35 | - | |
| 322 | Ubiquitination | DPNWHCPPCRGICNC CCCCCCCCCCCEECC | 26.32 | - | |
| 349 | Ubiquitination | GVLVYLAKYHGFGNV HHHHHHHHHCCCCCH | 34.87 | - | |
| 350 | Phosphorylation | VLVYLAKYHGFGNVH HHHHHHHHCCCCCHH | 11.10 | 24114839 | |
| 355 | Ubiquitination | AKYHGFGNVHAYLKS HHHCCCCCHHHHHHH | 21.82 | 29967540 | |
| 359 | Phosphorylation | GFGNVHAYLKSLKQE CCCCHHHHHHHHHHH | 10.37 | 24114839 | |
| 361 | Ubiquitination | GNVHAYLKSLKQEFE CCHHHHHHHHHHHHH | 40.86 | 29967540 | |
| 364 | Sumoylation | HAYLKSLKQEFEMQA HHHHHHHHHHHHHCC | 55.67 | - | |
| 364 | Ubiquitination | HAYLKSLKQEFEMQA HHHHHHHHHHHHHCC | 55.67 | 22505724 | |
| 364 | Sumoylation | HAYLKSLKQEFEMQA HHHHHHHHHHHHHCC | 55.67 | - | |
| 416 | Ubiquitination | ---------------------------------------------------- ---------------------------------------------------- | 22505724 | ||
| 428 (in isoform 2) | Ubiquitination | - | - | ||
| 440 | Ubiquitination | ---------------------------------------------------------------------------- ---------------------------------------------------------------------------- | 29967540 | ||
| 440 (in isoform 2) | Ubiquitination | - | - | ||
| 443 (in isoform 2) | Ubiquitination | - | - | ||
| 443 | Ubiquitination | ------------------------------------------------------------------------------- ------------------------------------------------------------------------------- | 22505724 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 163 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDCA7_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| 1433T_HUMAN | YWHAQ | physical | 26186194 | |
| 1433S_HUMAN | SFN | physical | 26186194 | |
| 1433Z_HUMAN | YWHAZ | physical | 26186194 | |
| 1433F_HUMAN | YWHAH | physical | 26186194 | |
| 1433Z_HUMAN | YWHAZ | physical | 28514442 | |
| 1433G_HUMAN | YWHAG | physical | 28514442 | |
| 1433F_HUMAN | YWHAH | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...